Background
The prevalence of sickle cell disease (SCD) in the Republic of Uganda is higher than in the United States, but there are no accurate countrywide data and no newborn screening program has been established. The Early Infant Diagnosis (EID) program is well established to analyze dried blood spots (DBSs) collected from HIV-exposed infants (ie, those born to HIV-positive mothers). HIV-positive infants are identified and placed into specialty care.
At the request of the Uganda Ministry of Health, a partnership was developed between Cincinnati Children's Hospital Medical Center, Makerere University, and the Uganda Central Public Health Laboratories (CHPL) to build local laboratory capacity for testing DBSs for sickle cell trait (SCT) and SCD.
The Uganda Sickle Surveillance Study (US3) was designed to identify SCT or SCD in DBSs collected throughout the national EID program. After US3, screening commenced in high-burden districts with local capacity built to provide clinical care for affected infants.
Objectives
To build local capacity for laboratory skills with the following specific objectives: (Table 1) . The overall prevalence of SCT was 13.3% and the prevalence of SCD was distribution was noted across Uganda with the highest burden in central regions. Samples were collected using targeted screening from the districts with the highest burden. Results confirm the high burden of SCT and SCD in Uganda, especially in the East Central and Mid-Northern regions. Affected infants and children were referred to local district hospitals for specialized care, using teaching guidelines provided by national health care experts. 
Screening and training efforts

Post-US3 screening results
Targeted screening of high-burden districts c 112 352 samples were tested from 2015 to 2018 (Table 1) . The prevalence of SCT (15.5%) and SCD (1.3%) was higher than in the original US3 study.
Uganda National Sickle Cell Laboratory c
After the local laboratory reached its maximum capacity, the new CPHL was expanded to include a large sickle cell laboratory. 
